NewData Clinical Research - Aracaju

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Asthma1 trial
• Crohn's disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Ulcerative colitis1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting4 trials

Lead sponsor

• Eli Lilly and Company4 trials

Running trials

• Recruiting

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Phase 2· Eli Lilly and Company· Source

  Contact: Ivan Mendes (principal investigator)

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  NCT06937086· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  NCT06937099· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Asthma1 recruiting
• Crohn's disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Ulcerative colitis1 recruiting